ENOV 📈 Enovis - Overview

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1940145022

ENOV: Orthopedic Braces, Surgical Implants, Therapy Systems, Pain Management Devices

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware. Web URL: https://www.enovis.com

Additional Sources for ENOV Stock

ENOV Stock Overview

Market Cap in USD 2,707m
Sector Industrials
Industry Specialty Industrial Machinery
GiC Sub-Industry Health Care Equipment
IPO / Inception 2008-05-08

ENOV Stock Ratings

Growth 5y -45.5%
Fundamental -46.8%
Dividend -
Rel. Strength Industry -519
Analysts 4.55/5
Fair Price Momentum 37.04 USD
Fair Price DCF 5.91 USD

ENOV Dividends

No Dividends Paid

ENOV Growth Ratios

Growth Correlation 3m 68.4%
Growth Correlation 12m -78.6%
Growth Correlation 5y -37.4%
CAGR 5y -6.96%
CAGR/Mean DD 5y -0.24
Sharpe Ratio 12m -0.92
Alpha -62.58
Beta 1.57
Volatility 32.39%
Current Volume 1258.4k
Average Volume 20d 608k
What is the price of ENOV stocks?
As of December 21, 2024, the stock is trading at USD 43.12 with a total of 1,258,420 shares traded.
Over the past week, the price has changed by -6.55%, over one month by -3.71%, over three months by -1.26% and over the past year by -21.54%.
Is Enovis a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Enovis (NYSE:ENOV) is currently (December 2024) not a good stock to buy. It has a ValueRay Fundamental Rating of -46.84 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ENOV as of December 2024 is 37.04. This means that ENOV is currently overvalued and has a potential downside of -14.1%.
Is ENOV a buy, sell or hold?
Enovis has received a consensus analysts rating of 4.55. Therefor, it is recommend to buy ENOV.
  • Strong Buy: 7
  • Buy: 3
  • Hold: 1
  • Sell: 0
  • Strong Sell: 0
What are the forecast for ENOV stock price target?
According to ValueRays Forecast Model, ENOV Enovis will be worth about 40.8 in December 2025. The stock is currently trading at 43.12. This means that the stock has a potential downside of -5.47%.
Issuer Forecast Upside
Wallstreet Target Price 66.3 53.8%
Analysts Target Price 70 62.3%
ValueRay Target Price 40.8 -5.5%